Advertisement

---

PRISM PHARMA CO., LTD.

PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications

[2013-06-13] - Data recently presented at ASCO demonstrates compound's potential in solid tumors


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers